Theriva Biologics Inc. (TOVX) — Cash Flow-to-Debt Ratio
Theriva Biologics Inc. (TOVX) has a Cash Flow-to-Debt Ratio of -0.11x as of March 2026, meaning its operating cash flow of $-2.46 Million could theoretically repay 0% of its total liabilities ($22.85 Million) in one year. See TOVX free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Theriva Biologics Inc. Cash Flow-to-Debt Ratio (1993–2025)
Historical debt coverage capacity for Theriva Biologics Inc. across 31 annual periods. Also explore net asset growth rate of Theriva Biologics Inc. to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Theriva Biologics Inc. (1993–2025)
Year-by-year debt coverage analysis for Theriva Biologics Inc.. For market capitalisation and broader financial context, see TOVX market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.73x | $-16.67 Million | $22.86 Million | ▲ +29.9% |
| 2024 | -1.04x | $-16.94 Million | $16.29 Million | ▲ +15.0% |
| 2023 | -1.22x | $-19.00 Million | $15.52 Million | ▼ -10.9% |
| 2022 | -1.10x | $-19.08 Million | $17.30 Million | ▲ +57.6% |
| 2021 | -2.60x | $-12.89 Million | $4.96 Million | ▲ +32.6% |
| 2020 | -3.86x | $-12.17 Million | $3.15 Million | ▼ -59.9% |
| 2019 | -2.41x | $-13.87 Million | $5.75 Million | ▲ +48.5% |
| 2018 | -4.69x | $-17.28 Million | $3.69 Million | ▼ -416.2% |
| 2017 | -0.91x | $-20.20 Million | $22.25 Million | ▲ +34.1% |
| 2016 | -1.38x | $-27.90 Million | $20.25 Million | ▲ +43.9% |
| 2015 | -2.45x | $-38.89 Million | $15.84 Million | ▼ -46.4% |
| 2014 | -1.68x | $-16.08 Million | $9.59 Million | ▲ +77.7% |
| 2013 | -7.52x | $-7.72 Million | $1.03 Million | ▲ +66.7% |
| 2012 | -22.57x | $-8.92 Million | $395.00K | ▼ -227.4% |
| 2011 | -6.89x | $-2.88 Million | $417.00K | ▼ -222.1% |
| 2010 | -2.14x | $-1.14 Million | $532.48K | ▲ +61.0% |
| 2009 | -5.49x | $-2.92 Million | $531.43K | ▲ +29.7% |
| 2008 | -7.82x | $-4.85 Million | $620.72K | ▼ -99.6% |
| 2007 | -3.92x | $-6.61 Million | $1.69 Million | ▼ -20.6% |
| 2006 | -3.25x | $-2.37 Million | $729.02K | ▼ -542.9% |
| 2005 | -0.50x | $-1.08 Million | $2.14 Million | ▼ -46.5% |
| 2002 | -0.34x | $-5.82 Million | $16.90 Million | ▲ +52.4% |
| 2001 | -0.72x | $-8.07 Million | $11.14 Million | ▲ +24.8% |
| 2000 | -0.96x | $-5.65 Million | $5.86 Million | ▲ +73.9% |
| 1999 | -3.69x | $-16.14 Million | $4.38 Million | ▲ +56.6% |
| 1998 | -8.50x | $-18.70 Million | $2.20 Million | ▼ -267.9% |
| 1997 | -2.31x | $-6.70 Million | $2.90 Million | ▲ +57.6% |
| 1996 | -5.45x | $-6.00 Million | $1.10 Million | ▲ +70.9% |
| 1995 | -18.75x | $-7.50 Million | $400.00K | ▼ -275.0% |
| 1994 | -5.00x | $-4.50 Million | $900.00K | ▲ +71.4% |
| 1993 | -17.50x | $-3.50 Million | $200.00K | — |